BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33988479)

  • 1. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
    Rachoń D
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):205-9. PubMed ID: 22421986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
    Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperandrogenism after menopause: Ovarian or adrenal origin?].
    Sarfati J; Moraillon-Bougerolle M; Christin-Maitre S
    Gynecol Obstet Fertil Senol; 2022 Oct; 50(10):675-681. PubMed ID: 35609786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to androgen excess in women: Clinical and biochemical insights.
    Cussen L; McDonnell T; Bennett G; Thompson CJ; Sherlock M; O'Reilly MW
    Clin Endocrinol (Oxf); 2022 Aug; 97(2):174-186. PubMed ID: 35349173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-secreting adrenal adenomas.
    Danilowicz K; Albiger N; Vanegas M; Gómez RM; Cross G; Bruno OD
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1099-102. PubMed ID: 12423821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
    Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
    BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
    Rojewska P; Meczekalski B; Bala G; Luisi S; Podfigurna A
    Gynecol Endocrinol; 2022 Jul; 38(7):537-542. PubMed ID: 35647677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism.
    Auer MK; Hawley JM; Lottspeich C; Bidlingmaier M; Sappl A; Nowotny HF; Tschaidse L; Treitl M; Reincke M; Keevil BG; Reisch N
    Eur J Endocrinol; 2022 Dec; 187(6):K47-K53. PubMed ID: 36239921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
    Kostakis EK; Gkioni LN; Macut D; Mastorakos G
    Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
    Mamoojee Y; Ganguri M; Taylor N; Quinton R
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.